The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology

Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology

October 1, 2012 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Reichlin

You Might Also Like
  • In Memoriam: Morris Reichlin, MD
  • NYU Langone’s Division of Rheumatology in Manhattan Advances Its Mission to Understand Rheumatic Diseases, Improve Patient Outcomes
  • ACR’s Lupus Initiative Advances Education Around Diagnosing, Treating Disease
Explore This Issue
October 2012
Also By This Author
  • To Measure is to Know
Dr. Reichlin in his laboratory
Dr. Reichlin in his laboratory

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Dr. Reichlin and his wife, Marianne, on a visit to Australia.
Dr. Reichlin and his wife, Marianne, on a visit to Australia.

Drs. Scofield and Reichlin perform on their trumpets at a holiday gathering.
Drs. Scofield and Reichlin perform on their trumpets at a holiday gathering.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
Dr. Reichlin (left) at a gathering of immunologists in Vienna.
Dr. Reichlin (left) at a gathering of immunologists in Vienna.

“Come to Oklahoma and have a good time!” Those were the words that persuaded John B. Harley, MD, PhD, to join Morris (“Moe”) Reichlin, MD, as a faculty member in Oklahoma City in the early 1980s, where Dr. Reichlin was busy establishing what would become a well-recognized rheumatology training program at the University of Oklahoma Health Sciences Center, as well as a world-class research program and clinical autoantibody testing facility at the Oklahoma Medical Research Foundation (OMRF). Dr. Harley, currently chief of pediatric rheumatology at the University of Cincinnati Children’s Hospital Medical Center, explains: “What Moe meant by ‘have a good time,’ of course, was to really enjoy the science.”

Dr. Reichlin’s infectious enthusiasm for conducting research has drawn countless pre- and postdoctoral fellows and colleagues to OMRF since 1981, when he and his wife Marianne and colleague Ira N. Targoff, MD, packed up their lab equipment and moved from Buffalo, N.Y., to Oklahoma City. Now a professor emeritus and affiliate of OMRF Arthritis and Clinical Immunology Research Program, Dr. Reichlin is known foremost in rheumatology and immunology circles as one of the discoverers of anti-Ro (SSA) antibodies—and as the man who put Oklahoma rheumatology research on the map.1 From its origins in 1981, the program has expanded from an initial 25 to 30, to a staff of nearly 200 individuals. “We had great success with our science, both nationally and internationally,” says Dr. Harley. “We worked really hard and, at the same time, we had a good time.”

Dr. Reichlin has been motivated during his more than five-decade-long, award-winning career by the quest to define the antigenic targets of autoimmunity in people with systemic lupus erythematosus (SLE), inflammatory myopathies, polymyositis, and dermatomyositis. Throughout that time, Dr. Reichlin also remained intimate with clinical work and teaching. “Patients were my guideline, in disease classification or characterization,” he says. “If it meant something to the patient, then it meant something to me, and I pursued it.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

A Path to Immunology

Dr. Reichlin says he always knew he would go into medicine. As an undergraduate, he majored in chemistry and believes it may have been his mother who had initially urged him to become a physician (“She was a very strong person,” he said). In the 1960s, he studied the immunochemical properties of hemoproteins, particularly hemoglobin and cytochrome c, honing his laboratory skills in the graduate department of biochemistry at Brandeis in Boston, and as a postdoctoral fellow of the National Institutes of Health (NIH) in biochemistry at the University of Rome.2-4 He developed reagents that could help distinguish a single amino acid difference in protein structure.5

Pages: 1 2 3 4 5 | Single Page

Filed Under: Career Development, Education & Training, Professional Topics, Profiles Tagged With: Immunology, inflammatory myopathy, patient care, Profile, Research, rheumatologist, Scleroderma, Sjögren's syndrome, Systemic lupus erythematosusIssue: October 2012

You Might Also Like:
  • In Memoriam: Morris Reichlin, MD
  • NYU Langone’s Division of Rheumatology in Manhattan Advances Its Mission to Understand Rheumatic Diseases, Improve Patient Outcomes
  • ACR’s Lupus Initiative Advances Education Around Diagnosing, Treating Disease
  • Rheumatologist Marc C. Hochberg, MD, MPH, Advances Epidemiology Through Collaborative Ties

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)